Patents by Inventor Kenneth Russell

Kenneth Russell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170326132
    Abstract: A method for reducing, inhibiting, and eliminating inflammation and pain by using an effective amount of iron chelator composition to balance oxidative activity at a cutaneous site of inflammation and pain. The composition contained in transdermal formulations and administered topically in accordance with the invention can be combined with one or more suitable carriers and can be administered in conjunction with one or more additional therapeutic agents.
    Type: Application
    Filed: May 13, 2016
    Publication date: November 16, 2017
    Inventor: KENNETH RUSSELL
  • Publication number: 20170306688
    Abstract: A door mullion receptacle box assembly includes a toe plate, a channel box and block components. When a mullion is removed from a building/room opening, the toe plate may be fixed in the mullion receptacle box thus creating a uniform threshold across the width of the door openings. Using the assembly described herein, however, there are no large diameter holes in the top of the toe plate and no projections into the opening that could be a trip hazard. The present assembly replaces traditional fixed sill blocks mounted to the floor, or to the top of a threshold to anchor the bottom of conventional mullions. A typical mullion is locked in place with a lock at the top of the mullion. When installed, this mullion is placed over the sill block at the sill and tilted into place and locked into a header block at the top of the mullion.
    Type: Application
    Filed: April 21, 2017
    Publication date: October 26, 2017
    Applicant: Frame & Mullions, LLC
    Inventors: James Thomas Clarke, JR., Kenneth Russell Snow
  • Patent number: 9613126
    Abstract: A database system uses indexes to improve performance. The system can use one or more of the following: differentiated subfields for index clustering; set function calculations to reduce the amount of I/O; and/or using an inferred index in a circular table.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: April 4, 2017
    Assignee: McAfee, Inc.
    Inventors: Howard D. Stewart, Kenneth Russell, Paul H. Whittington
  • Publication number: 20170079960
    Abstract: The present invention relates generally to the field of therapy. The invention particularly relates to insulin sensitisers and methods of regulating glucose homeostasis and to the therapeutic or prophylactic treatment of diseases and associated conditions, in which impaired glucose uptake due to insulin resistance is involved or implicated, such as diabetes, syndrome X, hyperglycaemia, vascular disease and kidney disease. The present invention further relates to compounds and agents and compositions thereof for use in the treatment methods.
    Type: Application
    Filed: September 26, 2016
    Publication date: March 23, 2017
    Inventors: Gregory Royce COLLIER, Kenneth Russell WALDER, James Alexander CAMPBELL, Juan-Carlos MOLERO-NAVAJAS, Nicky KONSTANTOPOULOS, Guy Yeoman KRIPPNER
  • Publication number: 20160293393
    Abstract: A voltage supply system for supplying an RF voltage to an RF resonant load comprising an ion-optical component of a mass spectrometer is disclosed. The system comprises a Direct Digital Synthesiser (“DDS”) arranged and adapted to output an RF voltage. The voltage supply system is arranged and adapted: (i) to vary the frequency of the RF voltage output by the Direct Digital Synthesiser, (ii) to determine a first resonant frequency of the RF resonant load comprising the ion-optical component, and (iii) to determine whether or not the generation of an RF voltage at the first resonant frequency by the Direct Digital Synthesiser would also result in the generation of a spur frequency close to the first resonant frequency.
    Type: Application
    Filed: September 17, 2014
    Publication date: October 6, 2016
    Inventors: David Gordon, Richard Barrington Moulds, Kenneth Russell Worthington
  • Patent number: 9452148
    Abstract: The present invention relates generally to the field of therapy. The invention particularly relates to insulin sensitizers and methods of regulating glucose homeostasis and to the therapeutic or prophylactic treatment of diseases and associated conditions, in which impaired glucose uptake due to insulin resistance is involved or implicated, such as diabetes, syndrome X, hyperglycaemia, vascular disease and kidney disease. The present invention further relates to compounds and agents and compositions thereof for use in the treatment methods.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: September 27, 2016
    Assignee: Verva Pharmaceuticals Ltd
    Inventors: Gregory Royce Collier, Kenneth Russell Walder, James Alexander Campbell, Juan-Carlos Molero-Navajas, Nicky Konstantopoulos, Guy Yeoman Krippner
  • Patent number: 9030293
    Abstract: Methods and devices for presenting a secure passcode system to a user are disclosed. The methods and devices may include a security prompt displayed to a user, wherein the prompt comprises a sequence of passcode elements. The passcode elements may comprise both response-eligible and response-ineligible passcode elements. The security prompt may receive an input from a user and determine whether the response is correct. A correct response may include each of the response-eligible passcode elements and none of the response-ineligible passcode elements. If a correct response is received, the security prompt may permit further access to a function.
    Type: Grant
    Filed: May 4, 2012
    Date of Patent: May 12, 2015
    Assignee: Google Inc.
    Inventors: Joshua Abraham Tabak, Kenneth Russell Carter
  • Patent number: 8869261
    Abstract: A method is disclosed for adjusting a security interface display on an electronic device. The method comprises a user of an electronic device requesting a change in the display of an interface for entering security code information on the device. The device presents to the user a variety of options related to the manner in which the graphical elements of the security interface may be displayed. The user may select any one or more of the display options. The electronic device thereafter displays a security interface with graphical elements displayed according to the user's selection.
    Type: Grant
    Filed: May 2, 2012
    Date of Patent: October 21, 2014
    Assignee: Google Inc.
    Inventor: Kenneth Russell Carter
  • Patent number: 8854368
    Abstract: Method, system, and computer-readable medium for emulating a point sprite represented by a three dimensional vertex in a cross platform environment. The system includes a three dimensional vertex representing a point sprite and a vertex and fragment shaders written in the first programming language. One or more variables are assigned to a set of points representing the 3D vertex using the vertex shader and convey information from the vertex shader to the fragment shader. The point sprite emulator translates the vertex and fragment shaders from the first programming language into a second programming language. The translation includes a transfer of each variable from the vertex shader to the fragment shader such that the information included in each variable is preserved. The point sprite is rendered from the 3D vertex using the translated vertex fragment shaders and displayed on a display screen.
    Type: Grant
    Filed: March 15, 2012
    Date of Patent: October 7, 2014
    Assignee: Google Inc.
    Inventor: Kenneth Russell
  • Publication number: 20140011848
    Abstract: The present invention relates generally to the field of therapy. The invention particularly relates to insulin sensitisers and methods of regulating glucose homeostasis and to the therapeutic or prophylactic treatment of diseases and associated conditions, in which impaired glucose uptake due to insulin resistance is involved or implicated, such as diabetes, syndrome X, hyperglycaemia, vascular disease and kidney disease. The present invention further relates to compounds and agents and compositions thereof for use in the treatment methods.
    Type: Application
    Filed: May 31, 2013
    Publication date: January 9, 2014
    Inventors: Gregory Royce Collier, Kenneth Russell Walder, James Alexander Campbell, Juan-Carlos Molero-Navajas, Nicky Konstantopoulos, Guy Yeoman Krippner
  • Publication number: 20130297615
    Abstract: A database system uses indexes to improve performance. The system can use one or more of the following: differentiated subfields for index clustering; set function calculations to reduce the amount of I/O; and/or using an inferred index in a circular table.
    Type: Application
    Filed: June 28, 2013
    Publication date: November 7, 2013
    Inventors: Howard D. Stewart, Kenneth Russell, Paul H. Whittington
  • Patent number: 8484220
    Abstract: A database system uses indexes to improve performance. The system can use one or more of the following: differentiated subfields for index clustering; set function calculations to reduce the amount of I/O; and/or using an inferred index in a circular table.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: July 9, 2013
    Assignee: McAfee, Inc.
    Inventors: Howard D. Stewart, Kenneth Russell, Paul H. Whittington
  • Patent number: 8455432
    Abstract: The present invention relates generally to the field of therapy. The invention particularly relates to insulin sensitizers and methods of regulating glucose homeostasis and to the therapeutic or prophylactic treatment of diseases and associated conditions, in which impaired glucose uptake due to insulin resistance is involved or implicated, such as diabetes, syndrome X, hyperglycaemia, vascular disease and kidney disease. The present invention further relates to compounds and agents and compositions thereof for use in the treatment methods.
    Type: Grant
    Filed: January 25, 2008
    Date of Patent: June 4, 2013
    Assignee: Verva Pharmaceuticals Ltd.
    Inventors: Gregory Royce Collier, Kenneth Russell Walder, James Alexander Campbell, Juan-Carlos Molero-Navajas, Nicky Konstantopoulos, Guy Yeoman Krippner
  • Patent number: 8412713
    Abstract: A database system uses indexes to improve performance. The system can use one or more of the following: differentiated subfields for index clustering; set function calculations to reduce the amount of I/O; and/or using an inferred index in a circular table.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: April 2, 2013
    Assignee: McAfee, Inc.
    Inventors: Howard D. Stewart, Kenneth Russell, Paul H. Whittington
  • Patent number: 8324446
    Abstract: A unitary absorbent core includes a nonwoven layer which has a body-facing surface and a garment-facing surface. At least a portion of a first binding agent is impregnated into the garment-facing surface. A superabsorbent material is located on the impregnated surface, and a second binding agent is located on the superabsorbent material and can be superimposed onto the first binding agent. The unitary absorbent core can be utilized for absorbing viscous fluids.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: December 4, 2012
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: James Hongxue Wang, Russell Paul George, Candace Dyan Krautkramer, Kenneth Russell Casson
  • Patent number: 8075084
    Abstract: Methods and systems are provided to increase or optimize the illumination used with a sensor to measure printed ink colors on a substrate at high speed (up to 3 m/s) and high resolution. By modifying the number of light sources, their wavelengths and/or their relative intensities, the optical contrast can be increased or optimized to yield a higher signal-to-noise ratio and improved accuracy for the measurement of multiple colors. In one implementation, multiple LEDs with selected output peak wavelength may be used to achieve higher contrast imaging for each color.
    Type: Grant
    Filed: July 10, 2008
    Date of Patent: December 13, 2011
    Assignee: Xerox Corporation
    Inventors: Kenneth Russell Ossman, R. Enrique Viturro
  • Publication number: 20110112167
    Abstract: The present invention relates to diagnostic and therapeutic methods in relation to diabetic complications, such as blindness, nephropathy and cardiovascular disease, and inflammatory conditions, such as angina, arthritis, empyema pharyngitis and urinary tract infection. Diagnostic methods involve screening for up regulated expression of decor (Den) or thioredoxin-like protein 19 (TLP 19). Therapeutic methods involve modulation of expression or activity o Den or TLP 19. The invention also relates to screening methods for identifying functional signal sequences to screen for secreted, membrane-bound and exported proteins and cell surface receptors.
    Type: Application
    Filed: May 17, 2006
    Publication date: May 12, 2011
    Applicant: AUTOGEN RESEARCH PTY LTD
    Inventors: Gregory Royce Collier, Kenneth Russell Walder, Janine Susan McMillan, David Harry Segal, Kelly Fiona Windmill, Kristy Ann Bolton
  • Publication number: 20110003740
    Abstract: The present invention relates generally to the field of therapy. The invention particularly relates to insulin sensitisers and methods of regulating glucose homeostasis and to the therapeutic or prophylactic treatment of diseases and associated conditions, in which impaired glucose uptake due to insulin resistance is involved or implicated, such as diabetes, syndrome X, hyperglycaemia, vascular disease and kidney disease. The present invention further relates to compounds and agents and compositions thereof for use in the treatment methods.
    Type: Application
    Filed: January 25, 2008
    Publication date: January 6, 2011
    Applicant: VERVA PHARMACEUTICALS LTD.
    Inventors: Gregory Royce Collier, Kenneth Russell Walder, James Alexander Campbell, Juan-Carlos Molero-Navajas, Nicky Konstantopoulos, Guy Yeoman Krippner
  • Publication number: 20100198830
    Abstract: Systems and methods reduce a time to calculate an aggregate of data values associated with a range of index entries. The system manages aggregate values within data stored in the entries of an index during insertion, modification, and deletion operations, and provides new index operations to generate aggregate values associated with a range of index entries. Multiple simultaneous operations can be executed efficiently.
    Type: Application
    Filed: September 3, 2009
    Publication date: August 5, 2010
    Inventors: Howard D. STEWART, Kenneth RUSSELL, Paul H. WHITTINGTON
  • Publication number: 20100007279
    Abstract: Methods and systems are provided to increase or optimize the illumination used with a sensor to measure printed ink colors on a substrate at high speed (up to 3 m/s) and high resolution. By modifying the number of light sources, their wavelengths and/or their relative intensities, the optical contrast can be increased or optimized to yield a higher signal-to-noise ratio and improved accuracy for the measurement of multiple colors. In one implementation, multiple LEDs with selected output peak wavelength may be used to achieve higher contrast imaging for each color.
    Type: Application
    Filed: July 10, 2008
    Publication date: January 14, 2010
    Applicant: XEROX CORPORATION
    Inventors: Kenneth Russell Ossman, E. Enrique Viturro